(Alliance News) –Oakley Capital Investments said Tuesday it has participated in an investment in a services provider to the life sciences industry.
The private equity firm specializing in the technology, consumer, education and business services sectors announced that Oakley Capital Fund V has agreed to invest in ProductLife Group, a European provider of regulatory and compliance outsourcing services to the global life sciences industry.
Oakley Capital Investments expects its commitments through Fund V to be around £41 million.
Xavier Dubruc, ProductLife’s chief executive officer, said: “We see significant opportunities to expand our business in the fragmented pharmaceutical services market, both through organic growth and acquisitions. Oakley has great expertise in buying and building and executing internationalization strategies, and we welcome the opportunity to work with the company in the next phase of the ProductLife Group.”
Peter Dubens, Founder and Managing Partner at Oakley Capital, said: “We are pleased to invest in Productlife Group. This is an attractive business in a large, non-cyclical market where increasing regulation and outsourcing are driving growth. At the same time, the group’s investments in technology assistance are expected to enhance its competitive advantage over the coming years. We look forward to working with Xavier and the management team to maximize this potential.”
Oakley Capital Investments shares fell 0.1% to 487.50 pence per share in London on Tuesday.
Tom Bazs, Alliance News Slots Editor
If you have any comments or questions please contact newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All rights reserved.
